Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
about
Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary diseaseExtrafine beclomethasone/formoterol compared to fluticasone/salmeterol combination therapy in COPDPatient's perception of symptoms related to morning activity in chronic obstructive pulmonary disease: the SYMBOL Study.Corticosteroid insensitivity is reversed by formoterol via phosphoinositide-3-kinase inhibitionBudesonide/formoterol combination in COPD: a US perspective.Pharmacological treatment of COPD.Budesonide/formoterol Turbuhaler®: a review of its use in chronic obstructive pulmonary disease.The potential for aclidinium bromide, a new anticholinergic, in the management of chronic obstructive pulmonary disease.Symptom variability in COPD: a narrative review.COPD symptoms in the morning: impact, evaluation and managementOnset of action of formoterol versus salmeterol via dry powder inhalers in moderate chronic obstructive pulmonary disease: a randomized, placebo-controlled, double-blind, crossover study.Inhaled treatment for chronic obstructive pulmonary disease: what's new and how does it fit?Morning symptoms in COPD: a treatable yet often overlooked factor.Morning and night symptoms in primary care COPD patients: a cross-sectional and longitudinal study. An UNLOCK study from the IPCRG.Tailoring of corticosteroids in COPD management.Perception of circadian variation of symptoms in Chinese patients with chronic obstructive pulmonary disease.Efficacy and safety of a 12-week treatment with twice-daily aclidinium bromide in COPD patients (ACCORD COPD I).DPP4 inhibitors increase differentially the expression of surfactant proteins in Fischer 344 rats.Real world COPD: association of morning symptoms with clinical and patient reported outcomes.Evaluation of the psychometric properties of the Early Morning Symptoms of COPD Instrument (EMSCI).
P2860
Q24197989-D52513D4-2592-44CD-902E-0E8164804E4AQ33558856-1978213F-5957-47EA-85ED-AFD2D1E8FBA7Q36485759-6023C2FF-7CBB-469B-87E3-5D2915373A4AQ36619748-796B1EE2-2850-4B3F-B41D-B17A2F72B67EQ37805343-FD2262BB-6D62-40A3-881D-BA1FA05E8EEBQ37924598-D5A374B1-73C0-4A15-846C-99CA0BECBD94Q37982436-1576E080-A3B2-440A-8709-8B4C81569230Q38052955-F6CEE821-6269-463C-9481-9E879D628214Q38107935-6605F2F4-21C6-4B3A-B0A8-4D3662B00955Q38154294-0FD1DA5B-F7E6-4F82-AB3B-9316919FE395Q38477843-753E37E3-E1F2-4DBF-BD83-2364CF0A82FEQ38630770-C1FE94B5-BBB4-4442-8B36-0EE5D57AA1C9Q38747579-2D06433F-070C-4A1F-A861-EFCE0F60FD43Q38839252-87A73175-03F6-48D2-A8E7-BD126D0A74A0Q42753079-1751D5CF-790D-46F7-8213-3322AD52220AQ47265611-CCBA2D46-EC8A-4B91-8925-A7A9A812AA87Q48485039-1DFF9468-4815-46D9-ABA1-46442B6A9F5AQ51707644-8E3F8A15-2A1B-4EF0-A4EC-46E60B4A4D02Q54757413-9A316B63-96E2-4974-ACA4-E1654D1F3556Q55384279-11948DA7-51F2-48BF-9BDF-01DE1E7AD021
P2860
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effect on lung function and mo ...... icasone in patients with COPD.
@en
Effect on lung function and mo ...... icasone in patients with COPD.
@nl
type
label
Effect on lung function and mo ...... icasone in patients with COPD.
@en
Effect on lung function and mo ...... icasone in patients with COPD.
@nl
prefLabel
Effect on lung function and mo ...... icasone in patients with COPD.
@en
Effect on lung function and mo ...... icasone in patients with COPD.
@nl
P2093
P2860
P356
P1476
Effect on lung function and mo ...... icasone in patients with COPD.
@en
P2093
Martyn R Partridge
Ola Beckman
Tomasz Polanowski
Tore Persson
Wolfgang Schuermann
P2860
P356
10.1177/1753465809344870
P577
2009-08-01T00:00:00Z